CymitQuimica logo

Methyl lucidenate D2

CAS:

Ref. 3D-FM74434

1mg
315.00€
2mg
483.00€
5mg
849.00€
Methyl lucidenate D2
Biosynth

Product Information

Name:Methyl lucidenate D2
Brand:Biosynth
Description:Methyl lucidenate D2 is a triterpenoid compound, which is a derivative isolated from the fruiting bodies of Ganoderma lucidum, a widely studied medicinal mushroom. This compound exhibits activity primarily through its ability to modulate various signaling pathways implicated in cancer cell proliferation and survival. Specifically, it has been observed to interfere with tumor growth by inducing apoptosis and cell cycle arrest in several cancer cell lines. The uses and applications of Methyl lucidenate D2 are mainly focused on cancer research, given its potential as an anticancer agent. It is utilized in experimental oncology for studying the biochemical pathways involved in cancer progression and for evaluating its efficacy and mechanisms as a therapeutic compound. Researchers may also explore its synergistic effects with other anticancer agents, aiming to enhance treatment outcomes. As such, Methyl lucidenate D2 represents a significant interest in the development of alternative and complementary approaches to cancer therapy.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Purity:Min. 95%

Technical inquiry about: Methyl lucidenate D2

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.